1986•Antimicrobial Agents and ChemotherapyOpen access

Ciprofloxacin therapy for Mediterranean spotted fever

Didier Raoult, H Gallais, P. De Micco, Paul Casanova

Abstract

We report the treatment of five patients with Mediterranean spotted fever with the antimicrobial agent ciprofloxacin. The treatment was administered intravenously for 2 days and then perorally for 8 days. All five patients were cured. These preliminary data seem to correlate with the in vitro activity of ciprofloxacin against Rickettsia conorii.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 62 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Rickettsia conorii, Ciprofloxacin, Spotted fever, Boutonneuse fever, Antimicrobial, Rickettsiosis, Antibiotics, Microbiology